Your browser doesn't support javascript.
loading
Reliability of multi-site UK Biobank MRI brain phenotypes for the assessment of neuropsychiatric complications of SARS-CoV-2 infection: The COVID-CNS travelling heads study.
Duff, Eugene; Zelaya, Fernando; Almagro, Fidel Alfaro; Miller, Karla L; Martin, Naomi; Nichols, Thomas E; Taschler, Bernd; Griffanti, Ludovica; Arthofer, Christoph; Douaud, Gwenaëlle; Wang, Chaoyue; Okell, Thomas W; Bethlehem, Richard A I; Eickel, Klaus; Günther, Matthias; Menon, David K; Williams, Guy; Facer, Bethany; Lythgoe, David J; Dell'Acqua, Flavio; Wood, Greta K; Williams, Steven C R; Houston, Gavin; Keller, Simon S; Holden, Catherine; Hartmann, Monika; George, Lily; Breen, Gerome; Michael, Benedict D; Jezzard, Peter; Smith, Stephen M; Bullmore, Edward T.
Afiliación
  • Duff E; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Zelaya F; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
  • Almagro FA; Department of Brain Sciences, UK Dementia Research Institute, Imperial College London, London, United Kingdom.
  • Miller KL; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Martin N; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Nichols TE; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Taschler B; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Griffanti L; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Arthofer C; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Douaud G; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Wang C; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Okell TW; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Bethlehem RAI; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Eickel K; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Günther M; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Menon DK; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom.
  • Williams G; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Facer B; mediri GmbH, Heidelberg, Germany.
  • Lythgoe DJ; mediri GmbH, Heidelberg, Germany.
  • Dell'Acqua F; University of Bremen, Bremen, Germany.
  • Wood GK; Fraunhofer MEVIS, Bremen, Germany.
  • Williams SCR; Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.
  • Houston G; Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Keller SS; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Holden C; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Hartmann M; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • George L; NatBrainLab, Department of Forensics and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Breen G; Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry Psychology and Neuroscience, King's College London, United Kingdom.
  • Michael BD; Clinical Infection Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, Liverpool, United Kingdom.
  • Jezzard P; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Smith SM; GE Healthcare, Global Research Organisation, United Kingdom.
  • Bullmore ET; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
PLoS One ; 17(9): e0273704, 2022.
Article en En | MEDLINE | ID: mdl-36173949
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / COVID-19 Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / COVID-19 Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos